Corline Biomedical (Sweden) Market Value
| CLBIO Stock | SEK 7.08 0.38 5.67% |
| Symbol | Corline |
Corline Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Corline Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Corline Biomedical.
| 12/14/2022 |
| 12/03/2024 |
If you would invest 0.00 in Corline Biomedical on December 14, 2022 and sell it all today you would earn a total of 0.00 from holding Corline Biomedical AB or generate 0.0% return on investment in Corline Biomedical over 720 days. Corline Biomedical is related to or competes with Immunovia Publ, Sedana Medical, KABE Group, IAR Systems, Mekonomen, Embellence Group, and Norva24 Group. Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cel... More
Corline Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Corline Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Corline Biomedical AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 18.53 | |||
| Value At Risk | (7.06) | |||
| Potential Upside | 6.59 |
Corline Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Corline Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Corline Biomedical's standard deviation. In reality, there are many statistical measures that can use Corline Biomedical historical prices to predict the future Corline Biomedical's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.99) | |||
| Treynor Ratio | 0.3999 |
Corline Biomedical Backtested Returns
Corline Biomedical secures Sharpe Ratio (or Efficiency) of -0.0617, which signifies that the company had a -0.0617% return per unit of risk over the last 3 months. Corline Biomedical AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Corline Biomedical's Risk Adjusted Performance of (0.06), mean deviation of 3.03, and Standard Deviation of 4.15 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.93, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Corline Biomedical are expected to decrease slowly. On the other hand, during market turmoil, Corline Biomedical is expected to outperform it slightly. At this point, Corline Biomedical has a negative expected return of -0.25%. Please make sure to confirm Corline Biomedical's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Corline Biomedical performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.45 |
Modest reverse predictability
Corline Biomedical AB has modest reverse predictability. Overlapping area represents the amount of predictability between Corline Biomedical time series from 14th of December 2022 to 9th of December 2023 and 9th of December 2023 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Corline Biomedical price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Corline Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 6.48 |
Corline Biomedical lagged returns against current returns
Autocorrelation, which is Corline Biomedical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Corline Biomedical's stock expected returns. We can calculate the autocorrelation of Corline Biomedical returns to help us make a trade decision. For example, suppose you find that Corline Biomedical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Corline Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Corline Biomedical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Corline Biomedical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Corline Biomedical stock over time.
Current vs Lagged Prices |
| Timeline |
Corline Biomedical Lagged Returns
When evaluating Corline Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Corline Biomedical stock have on its future price. Corline Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Corline Biomedical autocorrelation shows the relationship between Corline Biomedical stock current value and its past values and can show if there is a momentum factor associated with investing in Corline Biomedical AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Corline Stock Analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.